Herve Farine
Allschwil, BL, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Multiple-ascending doses of ACT-1014-6470, an oral complement factor 5a receptor 1 (C5a1 receptor) antagonist: Tolerability, pharmacokinetics and target engagement.
Journal: British journal of clinical pharmacology
Published: May 25, 2022
Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients.
Journal: Molecular genetics and metabolism reports
Published: December 13, 2021
Immunoaffinity Targeted Mass Spectrometry Analysis of Human Plasma Samples Reveals an Imbalance of Active and Inactive CXCL10 in Primary Sjögren's Syndrome Disease Patients.
Journal: Journal of proteome research
Published: September 02, 2020
Impact of high-altitude therapy on type-2 immune responses in asthma patients.
Journal: Allergy
Published: December 22, 2018
Pharmacokinetics, pharmacodynamics, tolerability and prediction of clinically effective dose of ACT-774312: A novel CRTH2 antagonist.
Journal: Basic & clinical pharmacology & toxicology
Published: October 19, 2018
Monitoring inflammatory heterogeneity with multiple biomarkers for multidimensional endotyping of asthma.
Journal: The Journal of allergy and clinical immunology
Published: February 12, 2017
A novel CRTH2 antagonist: Single- and multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ACT-453859 in healthy subjects.
Journal: Journal of clinical pharmacology
Published: November 10, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026